BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24435163)

  • 1. Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow.
    Gazi E; Temiz A; Altun B; Barutcu A; Silan F; Colkesen Y; Ozdemir O
    Cardiovasc J Afr; 2014; 25(1):9-14. PubMed ID: 24435163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the five gene related endothelial cell dysfunction polymorphisms with Buerger's disease development.
    Masoudian M; Fazeli B; Sharebiani H; Rajabnejad A; Ravari H; Akbarin MM; Dadgarmoghaddam M
    Int Angiol; 2016 Apr; 35(2):205-11. PubMed ID: 26406963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease.
    Agirbasli M; Guney AI; Ozturhan HS; Agirbasli D; Ulucan K; Sevinc D; Kirac D; Ryckman KK; Williams SM
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):803-9. PubMed ID: 21450592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between the Glu298Asp polymorphism of endothelial nitric oxide synthase and slow coronary flow in the Turkish population.
    Caglayan AO; Kalay N; Saatci C; Yalcýn A; Akalýn H; Dundar M
    Can J Cardiol; 2009 Mar; 25(3):e69-72. PubMed ID: 19279989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
    Sakhteh M; Poopak B; Amirizadeh N; Shamshiri A; Bagheri A; Faranoush M
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1168-74. PubMed ID: 25501306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
    Ozkan B; Cagliyan CE; Elbasan Z; Uysal OK; Kalkan GY; Bozkurt M; Tekin K; Bozdogan ST; Ozalp O; Duran M; Sahin DY; Cayli M
    Coron Artery Dis; 2012 Sep; 23(6):400-3. PubMed ID: 22850480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
    Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.
    Tanriverdi H; Evrengul H; Mergen H; Acar C; Seleci D; Kuru O; Tanriverdi S; Kaftan A
    Heart Vessels; 2007 Jan; 22(1):1-8. PubMed ID: 17285438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow.
    Tanriverdi H; Evrengul H; Enli Y; Kuru O; Seleci D; Tanriverdi S; Tuzun N; Kaftan HA; Karabulut N
    Cardiology; 2007; 107(4):313-20. PubMed ID: 17264512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in patients with asthma: the role of polymorphisms of ACE and endothelial NOS genes.
    Yildiz P; Oflaz H; Cine N; Genchallac H; Erginel-Unaltuna N; Yildiz A; Yilmaz V
    J Asthma; 2004 Apr; 41(2):159-66. PubMed ID: 15115168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in NOS3, ACE and PAI-1 genes and risk of spontaneous recurrent miscarriage in the Gaza Strip.
    Al Sallout RJ; Sharif FA
    Med Princ Pract; 2010; 19(2):99-104. PubMed ID: 20134171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
    Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
    Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults.
    Sampaio MF; Hirata MH; Hirata RD; Santos FC; Picciotti R; Luchessi AD; de Quateli Doi S; Armaganijan D; Batlouni M
    Clin Chim Acta; 2007 Feb; 377(1-2):154-62. PubMed ID: 17126309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial function in patients with slow coronary flow.
    Sezgin AT; Sigirci A; Barutcu I; Topal E; Sezgin N; Ozdemir R; Yetkin E; Tandogan I; Kosar F; Ermis N; Yologlu S; Bariskaner E; Cehreli S
    Coron Artery Dis; 2003 Apr; 14(2):155-61. PubMed ID: 12655279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of endothelial dysfunction and inflammation on slow coronary flow.
    Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.